NMTC NeuroOne Medical Technologies Corp
1,659
$1.17
$0.00
(0.00%)
| Watchers | 1,659 |
| 52-Wk Low | $0.85 |
| 52-Wk High | $2.00 |
| Market Cap | $30.34M |
| Volume | 827,315.00 |
| 52-Wk High | $2.00 |
| 52-Wk Low | $0.85 |
NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co.Globe Newswire • about 1 month ago
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ( NeuroOne or the Company ), a medical technology company focused on improving...
Share to Feed
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...
Wealth Alliance Advisory Group LLC purchased a new position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC Free Report) during the fourth quarter, according to its most recent Form 13F...
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne Medical Technologies (NASDAQ:NMTC Get Free Report) and Ion Beam Applications (OTCMKTS:IOBCF Get Free Report) are both medical companies, but which is the superior business...
Nova Eye Medical (OTCMKTS:ELXMF Get Free Report) and NeuroOne Medical Technologies (NASDAQ:NMTC Get Free Report) are both medical companies, but which is the superior stock? We will...
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript...
EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ( NeuroOne or the Company ), a medical technology company focused on improving...
NeuroOne Medical Tech (NASDAQ:NMTC) est cens e annoncer ses derniers b n fices ce mardi. Voici le guide essentiel de Benzinga\ au rapport de r sultats du premier trimestre de NeuroOne Medical Tech.
D...